For those interested SM1 meeting today at 10 a.m Aust time, one of the slides, it is being streamed.
SYNLAIT’S WORLD CLASS ADVANCED NUTRITION CAPABILITIES POSITIONS IT FOR ACCELERATED GROWTH This is underpinned by our strong and enduring relationship with The a2 Milk Company, dating back ten years. • State Administration for Market Regulation (SAMR) licence for The a2 Milk Company’s Chinese labelled 至初® Infant Formula owned by Synlait. • Evergreen manufacturing and supply arrangement has exclusivity arrangements. • Significant lift in The a2 Milk Company demand requires additional shifts. • New opportunities developing in the USA – temporary FDA approval.
A2M Price at posting:
$6.27 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)